Sandler O’Neill set a $47.00 target price on MetLife (NYSE:MET) in a report published on Thursday morning. The brokerage currently has a hold rating on the financial services provider’s stock.
Other equities analysts have also issued research reports about the company. Zacks Investment Research raised MetLife from a hold rating to a buy rating and set a $58.00 price objective on the stock in a research note on Thursday, January 18th. Wells Fargo set a $60.00 price objective on MetLife and gave the stock a buy rating in a research note on Tuesday, February 13th. ValuEngine lowered MetLife from a strong-buy rating to a buy rating in a research note on Friday, February 2nd. Goldman Sachs reissued a buy rating on shares of MetLife in a research note on Wednesday, January 31st. Finally, Keefe, Bruyette & Woods reissued a buy rating and set a $56.00 price objective on shares of MetLife in a research note on Friday, February 23rd. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have assigned a buy rating to the company. MetLife presently has a consensus rating of Hold and an average price target of $56.75.
Shares of NYSE:MET opened at $45.27 on Thursday. The company has a current ratio of 0.15, a quick ratio of 0.15 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $46,928.83, a PE ratio of 10.06, a PEG ratio of 0.74 and a beta of 1.24. MetLife has a 1 year low of $43.38 and a 1 year high of $55.91.
MetLife (NYSE:MET) last released its quarterly earnings data on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.41). The company had revenue of $15.79 billion for the quarter, compared to analyst estimates of $15.89 billion. MetLife had a return on equity of 8.59% and a net margin of 5.69%. During the same period last year, the firm posted $1.28 EPS. research analysts anticipate that MetLife will post 4.91 EPS for the current fiscal year.
Large investors have recently bought and sold shares of the business. First Dallas Securities Inc. purchased a new stake in MetLife in the fourth quarter valued at $111,000. Wagner Wealth Management LLC purchased a new stake in MetLife in the fourth quarter valued at $126,000. Sandy Spring Bank raised its position in MetLife by 495.2% in the fourth quarter. Sandy Spring Bank now owns 2,375 shares of the financial services provider’s stock valued at $120,000 after purchasing an additional 1,976 shares during the period. Valeo Financial Advisors LLC purchased a new stake in MetLife in the third quarter valued at $151,000. Finally, Avestar Capital LLC purchased a new stake in MetLife in the fourth quarter valued at $135,000. Institutional investors own 77.69% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “MetLife (MET) Given a $47.00 Price Target at Sandler O’Neill” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/04/09/metlife-met-given-a-47-00-price-target-at-sandler-oneill.html.
MetLife, Inc, through its subsidiaries, engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.